A recent study in Science uses bioinformatic analysis as well as biochemical and structural studies to characterize a novel family of effector proteins, named Cami1. The research shows that when a virus attacks a bacterium, CRISPR-Cas10 signaling molecules activate Cami1—a ribosome-dependent ribonuclease.
